Diagnostic Accuracy of Imaging Findings in TBM/Spinal Tubercular Arachnoiditis and Correlation With Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-27

Study Completion Date

2024-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this Diagnostic accuracy study is

* To study sensitivity and specificity of sulcal tuberculomas in the diagnosis of tubercular meningitis and
* To study the correlation of imaging findings in tubercular meningitis and spinal tubercular arachnoiditis with clinical outcomes after completion of therapy
* Secondary objectives
* To study the proportion of patients having clinical or imaging features of spinal tubercular arachnoiditis
* To study the factors determining outcomes in patients with spinal tubercular arachnoiditis
* To study the treatment trends in patients with spinal tubercular arachnoiditis

The investigators will include \[study Population\] Patients with chronic meningitis as per criteria listed below

* Chronic meningitis : Case definition
* Headache with or without fever, nuchal stiffness and systemic symptoms AND
* CSF suggestive of meningitis Pleocytosis (\>20 cells per μL) with lymphocyte predominance (\>50%) OR Protein concentration greater than age-specific normal value; especially \>1•0 g/L OR Glucose concentration less than 60% of concentration in blood OR MRI suggestive of meningeal enhancement on contrast enhanced T1 sequences AND
* Deemed by the treating physician that the syndrome is consistent with chronic meningitis
* Patients who are positive for antibodies to HIV and pregnant females will also be included.
* Willing to undergo periodic assessment clinically and with MRI as per clinical condition demands.

The sensitivity and specificity of the finding of sulcal tuberculomas will be compared to the reference standard diagnostic criteria for the diagnosis of TB meningitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Diffusion Tensor Imaging of Myelopathy

NCT03665935

Myelopathy

UNKNOWN

A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning

NCT03170531

Healthy

COMPLETED

Frequency ,Etiology and Prognostic Factors of Acute Transverse Myelitis

NCT06055998

Transverse Myelitis

NOT_YET_RECRUITING

Quantiative MRI and Myelin-PET for the Assessment of Degenerative Cervical Myelopathy

NCT05242666

Cervical Spondylosis With Myelopathy Degenerative Cervical Myelopathy

UNKNOWN NA

Changes in the MRI Signal in Patients With Benign Tumors of the Brain and Meninges Treated With Proton Therapy: Impact of TEL and the Biological Dose Received

NCT04584086

Benign Brain Tumors Proton Therapy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Methodology of the study Study design:Ambispective cohort study; Observational study; Diagnostic accuracy study

Sample size: All consecutive patients in the database will be included in the retrospective study and all new patients registered in the neurology OPD and admitted in the Neurology or General Medicine or Geriatric medicine or Medical oncology wards will be included in the prospective arm

Expecting a sensitivity of 70% of sulcal tuberculomas in tubercular meningitis with a range of 60 to 80, the investigators expect (4\*70\*30) /10\*10=84 patients Expecting sulcal tuberculomas to have a specificity of 80%, with a range of 70 to 90%, the investigators expect (4\*80\*20)/10\*10=64 patients Expecting a 70% prevalence of tubercular meningitis amongst patients with chronic meningitis, sample size of atleast 120 patients (70% of 120=84).

Subjects:

* Study Population: Patients with chronic meningitis as per criteria described
* Inclusion criteria

* Patients attending Neurology OPD or are admitted in General Medicine or Geriatric medicine or Medical oncology wards with chronic meningitis diagnosed on the basis of composite clinical criteria, imaging criteria as well as natural history of the illness
* Atleast 14 years of age of all sexes
* Chronic meningitis : Case definition above
* Willing to undergo periodic assessment clinically and with MRI as per clinical condition demands.
* Diagnostic criteria for Tuberculous meningitis ▪ Described in the diagnostic test section ahead
* Diagnostic criteria for clinical spinal tubercular arachnoiditis

▪ Developed paraparesis/quadriparesis/sphincter dysfunction due to spinal radiculomyelitis OR areflexia OR hyperreflexia with no obvious brain parenchymal lesions (suggestive of spinal meningitis-myelitis) or vision loss due to optico-chiasmatic arachnoiditis with imaging evidence of arachnoiditis
* Sample Size: All consecutive patients presenting with chronic meningitis as described above will be included

Exclusion criteria for prospective arm

● Not willing to provide consent

Conduct of the study

* Study protocol

* Consent: Participants or their legally authorized representatives will be explained about the study and informed written consent will be taken in the language they understand for the prospective study
* Participants will undergo magnetic resonance imaging of the brain and spine with contrast using the standardized protocol for chronic meningitis used at AIIMS as the standard of care in the workup of chronic meningitis.
* The final diagnosis of Tubercular meningitis will be made based on the criteria described above and the sensitivity and specificity of sulcal tuberculomas in the diagnosis of TBM will be determined
* Other imaging findings of spinal tubercular arachnoiditis will be collected on a structured proforma by the radiologist who will be blinded to the clinical information on the presence or absence of clinical features.
* Participants will follow treatment for tuberculosis as per the treating physician's discretion in terms of anti-tubercular therapy, anti-seizure medication therapy, duration and dose of corticosteroids and steroid sparing agents.
* Data collection and analysis will be done as per protocol Follow up and outcomes assessed \> Participants of the prospective arm will be carefully assessed with detailed history, clinical examination, necessary laboratory investigations and imaging \> Detailed history and clinical and neurologic examination, lab parameters and imaging data will be documented into a database as per protocol \> Participants will follow treatment for his/her primary condition as per the treating physician's discretion \> Outcomes will be assessed at 3 months, 6 months and at end of therapy \> The outcome parameters of interest will be modified Rankin scale, visual acuity at 3 months and end of therapy.

Diagnostic accuracy of imaging parameters in the diagnosis of tubercular meningitis will be assessed by sensitivity and specificity.

The investigators aim to do a descriptive study of the clinical, laboratory and imaging parameters of patients tubercular meningitis and spinal tubercular arachnoiditis and compare with patients with other forms of chronic meningitis.

The treatment strategy, usage of anti-tubercular therapy, usage of corticosteroids, steroid sparing therapy, and surgical interventions offered will be studied.

Outcomes will be assessed and compared those who have sulcal tuberculumas and those who don't. The patients with and without spinal arachnoiditis on imaging also will be compared, and their outcomes assessed. Factors affecting outcomes will be studied and exploratory analysis will be done. Statistical analysis will be performed on the available information. Qualitative data will be presented as the number and the percentage of patients in each treatment group. Quantitative data will be presented as mean and standard deviation, range, median and inter-quartile range by treatment group. The absence of imbalance between groups will be checked on baseline variables. Comparisons of qualitative variables between groups will be performed by a Fisher exact test; comparison of quantitative data will be performed by a t test or a comparison of median when they will not follow a Normal distribution. All statistical tests will be performed with the use of a two-sided type I error rate of 5%.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculous Meningitis Tuberculous Arachnoiditis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chronic Meningitis

* Chronic meningitis : Case definition

* Headache with or without fever, nuchal stiffness and systemic symptoms AND
* CSF suggestive of meningitis Pleocytosis (\>20 cells per μL) with lymphocyte predominance (\>50%) OR Protein concentration greater than age-specific normal value; especially \>1•0 g/L OR Glucose concentration less than 60% of concentration in blood OR MRI suggestive of meningeal enhancement on contrast enhanced T1 sequences AND
* Deemed by the treating physician that the syndrome is consistent with chronic meningitis
* Patients who are positive for antibodies to HIV and pregnant females will also be included.

MRI Brain and spine

Intervention Type DIAGNOSTIC_TEST

* MRI Brain
* Ax T2 TSE
* 3D Sag T1
* Ax DWI
* 3D Sag Flair
* Ax SWI
* Post-gad 3D Sag T1
* 3D TOF Circle-of-Willis
* MRI Spine
* Sag T2 whole spine (2 stations)
* Post-gad Sag T1 whole spine (2 stations)

Reference standard diagnostic criteria

Intervention Type DIAGNOSTIC_TEST

Diagnostic criteria-TBM

* Microbiologic evidence of TB in CSF
* Microbiologic evidence of TB from pulmonary or extrapulmonary sites
* Reasonable clinical certainty OR allied investigations such as CXR/CECT chest/abdomen/PET CT as per clinical indication suggestive of tuberculosis
* Other relevant investigations like CSF analysis not suggestive of alternative diagnosis such as neurocysticercosis/cryptococcal/other fungal infections/other causes of chronic meningitis such as brucella/ nocardia/ syphilis/recurrent viral meningitis/ carcinomatous/ lymphomatous meningitis or non infective causes such as sarcoidoisis/sub-arachnoid hemorrhage etc.
* Reasonable clinical certainty OR allied investigations such as CXR/CECT chest/abdomen/PET CT as per clinical indication ruling out competing diagnoses
* Patients who develop features or test results suggestive of alternative diagnosis with will be considered to be not due to tubercular meningitis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI Brain and spine

* MRI Brain
* Ax T2 TSE
* 3D Sag T1
* Ax DWI
* 3D Sag Flair
* Ax SWI
* Post-gad 3D Sag T1
* 3D TOF Circle-of-Willis
* MRI Spine
* Sag T2 whole spine (2 stations)
* Post-gad Sag T1 whole spine (2 stations)

Intervention Type DIAGNOSTIC_TEST

Reference standard diagnostic criteria

Diagnostic criteria-TBM

* Microbiologic evidence of TB in CSF
* Microbiologic evidence of TB from pulmonary or extrapulmonary sites
* Reasonable clinical certainty OR allied investigations such as CXR/CECT chest/abdomen/PET CT as per clinical indication suggestive of tuberculosis
* Other relevant investigations like CSF analysis not suggestive of alternative diagnosis such as neurocysticercosis/cryptococcal/other fungal infections/other causes of chronic meningitis such as brucella/ nocardia/ syphilis/recurrent viral meningitis/ carcinomatous/ lymphomatous meningitis or non infective causes such as sarcoidoisis/sub-arachnoid hemorrhage etc.
* Reasonable clinical certainty OR allied investigations such as CXR/CECT chest/abdomen/PET CT as per clinical indication ruling out competing diagnoses
* Patients who develop features or test results suggestive of alternative diagnosis with will be considered to be not due to tubercular meningitis

Intervention Type DIAGNOSTIC_TEST